Use of short-term tests in determining the genotoxicity or nongenotoxicity of chemicals
Related Experiment Video
Updated: Aug 10, 2026

08:25
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
1ICI Central Toxicology Laboratory, Macclesfield, Cheshire, United Kingdom.
IARC Scientific Publications
|January 1, 1992
Abstract:
This article brings together the several current approaches to the use of short-term tests for identifying carcinogens and the several meanings of the term 'genotoxic'. Examples of genotoxic and nongenotoxic carcinogens and of genotoxic and nongenotoxic mechanisms of carcinogenesis are discussed. Emphasis is placed on the determination of genotoxicity as it affects evaluation of the mechanism of action of a new rodent carcinogen.
Related Concept Videos
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

